300294 China Resources Boya Bio-pharmaceutical Group
- 33.32
- -0.01-0.03%
About China Resources Boya Bio-pharmaceutical Group Company
The company was founded in 1993. It is a blood products platform in China Resources Health. It is a comprehensive pharmaceutical industry group focusing on blood products business, integrating biochemicals, chemicals, APIs, etc., and is one of the few enterprises with a complete range of products in the three categories of human blood albumin, human immunoglobulin, and coagulation factors in the country. The company is mainly engaged in R&D, production and sales of blood products, including three types of products: albumin, immunoglobulins and coagulation factors. The company's products cover 9 varieties of 23 specifications, including human blood albumin, intravenous human immunoglobulin (pH4), and coagulation factors. Corporate honors: It has successively won honorary awards such as Forbes China's Top 100 Potential Listed Companies in 2013, 2014 and 2016, China's Top 50 Listed Companies in 2014, China's Top 100 Listed Companies Most Respected by Investors in 2015, China's Top 150 Listed Companies by Jinniu Value Investors in 2016, and Top 10 Pharmaceutical Companies with the Most Investment Value in 2017.
Company Profile
Company Executives
- Name
- Position
- Salary
- kai qiu
- Chairman, Directors, Member of the Strategy and ESG Committee, Member of the Nomination, Remuneration and Assessment Committee
- --
- jinni sun
- Directors, Member of the Strategy and ESG Committee
- --
- huacheng liang
- Directors, Board Secretary, Deputy General Manager, Chief Financial Officer
- 1.69M
- xiaoming liang
- Directors, General Manager, Member of the Strategy and ESG Committee
- 4.02M
- yuxuan pan
- Directors, Audit Committee Member
- --
- jinfeng shen
- Directors, Member of the Strategy and ESG Committee
- --
- weidong zhang
- Independent Directors, Member of the Nomination, Remuneration and Assessment Committee, Audit Committee Convener
- 200.00K
- li zhao
- Independent Directors, Audit Committee Member, Member of the Strategy and ESG Committee
- 200.00K
- huasheng huang
- Independent Directors, Nomination, Remuneration and Assessment Committee Convener
- 200.00K
- dongke peng
- Securities Affairs Representative
- --
- na tang
- Chairman of the Supervisory Board, Auditors
- --
- guiling tan
- Auditors
- --
- shuanhong zhang
- VP
- 1.27M
- shousun li
- Deputy General Manager
- 2.48M
- bing chen
- Deputy General Manager
- 6.54M
- kaiheng han
- Head of Internal Audit
- --
- zhen rao
- Employee Supervisors
- 1.03M
Analysis
Price Target
No Data
